19 results
424B3
PTPI
Petros Pharmaceuticals Inc
14 Jan 22
Prospectus supplement
5:18pm
or clinical trials, which could result in regulatory sanctions and cause serious harm to Petros’ reputation.
Additionally, Petros is subject to the risk … proprietary and confidential information, which could harm our business and reputation or cause us to incur increased expenses to address any
424B5
2noe9qjc
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
rds7jfpb gft0pz1
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B5
9hpt rlwvnuvxsxxsg
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-K
oav 0b7q5bmv
31 Mar 21
Annual report
4:30pm
S-3
yv4yvqjl 5mou
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-10.1
i0pkl2q
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
424B3
otcmnyk
2 Nov 20
Prospectus supplement
12:00am
S-4/A
mc2endwu
30 Sep 20
Registration of securities issued in business combination transactions (amended)
9:21am
S-4
075wcfuw rpxt6uh0
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next